Approved indications: In the U.S., diclofenac sodium oral tablets are approved in adults to relieve signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis; other oral diclofenac formulations are approved to treat mild‑to‑moderate acute pain, primary dysmenorrhea (menstrual cramps), and acute migraine attacks.

Common off‑label uses and evidence:

• Short‑term treatment of other musculoskeletal pains (such as acute low back pain, sprains, and post‑operative pain) when an oral NSAID is appropriate; evidence is generally good and similar to ibuprofen or naproxen.
• Occasional use in acute gout flares and other inflammatory arthritides when standard NSAID therapy is indicated; evidence is mostly extrapolated from other NSAIDs and smaller studies.

Efficacy expectations: For arthritis, many people notice some pain relief within several days, with maximal benefit often reached after 1–2 weeks of regular dosing; for acute pain, menstrual cramps, or migraine (with the appropriate oral formulation), improvement usually begins within 30–60 minutes and peaks within a few hours. Clinical trials show diclofenac provides pain and anti‑inflammatory relief comparable to other oral NSAIDs (such as ibuprofen and naproxen), though it does not cure the underlying disease; some large studies suggest diclofenac may carry a somewhat higher cardiovascular risk than naproxen, so choice among NSAIDs often depends on individual heart and stomach risk factors rather than differences in pain relief.

Typical adult dosing (oral diclofenac sodium tablets): For osteoarthritis, usual doses are 100–150 mg per day in divided doses (for example, 50 mg two or three times daily or 75 mg twice daily); for rheumatoid arthritis, 150–200 mg per day in divided doses; and for ankylosing spondylitis, about 100–125 mg per day (often 25 mg four times daily with an optional extra 25 mg at bedtime). Many clinicians aim for the lowest effective daily dose, typically not exceeding 150–200 mg/day, and shortest duration compatible with treatment goals.

How to take: Swallow tablets whole with a full glass of water; delayed‑release and extended‑release forms should not be crushed or chewed. They may be taken with food, milk, or a snack to reduce stomach upset, but follow the specific product instructions your prescriber gives you. Avoid taking more than one oral NSAID (such as ibuprofen, naproxen, or other diclofenac products) at the same time unless your clinician has specifically advised it.

Special dosing instructions: Dose reductions or extra monitoring may be needed in older adults and in people with kidney, liver, or cardiovascular disease. For chronic conditions like arthritis, regular daily dosing as prescribed is usually necessary for best effect; for short‑term pain, the medicine is often used only as needed for the briefest possible period.

Missed dose: If you miss a dose and remember relatively soon, take it when you remember; if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double doses to make up for a missed one.

Overdose: Taking too much diclofenac can cause severe stomach or intestinal bleeding, drowsiness, confusion, kidney problems, or serious cardiovascular or liver events; if an overdose is suspected, contact emergency services or a poison control center immediately.

Common side effects: The most frequent problems are stomach‑related (indigestion, heartburn, abdominal pain, nausea, diarrhea) and headache, dizziness, or drowsiness; mild swelling of the legs or ankles and elevated blood pressure can also occur. These effects often appear within days to weeks of starting treatment and are usually mild to moderate, but they are more likely at higher doses or with longer use.

Serious or rare adverse effects (seek immediate medical care): Stop the drug and get urgent help for chest pain, shortness of breath, sudden weakness or trouble speaking (possible heart attack or stroke); black or bloody stools, vomiting blood, or severe stomach pain (possible bleeding ulcer); sudden weight gain, swelling, or decreased urination (kidney injury or heart failure); yellowing of skin or eyes, dark urine, or severe fatigue (liver injury); wheezing, severe rash, blistering or peeling skin, or swelling of face, lips, or throat (allergic or severe skin reaction).

Warnings and precautions: Diclofenac, like all systemic NSAIDs, carries boxed warnings for increased risk of serious cardiovascular events (heart attack, stroke) and serious gastrointestinal bleeding, ulcer, and perforation; risk is higher in people with heart disease, high blood pressure, history of ulcers or GI bleeding, older age, or those taking certain other medicines. It should not be used right before or after coronary artery bypass graft (CABG) surgery, in people with a history of severe NSAID‑induced allergic reactions or aspirin‑sensitive asthma, or in active GI bleeding. Use cautiously in kidney or liver disease, heart failure, uncontrolled hypertension, and in older adults. In pregnancy, NSAIDs are generally avoided in the third trimester because they can affect the fetal heart and kidneys and the timing of labor, and they are used only if clearly needed earlier in pregnancy; during breastfeeding, small amounts pass into milk, so providers weigh risks and benefits. Safety and dosing are not well established in children for diclofenac sodium tablets, so pediatric use is typically limited to specialist direction.

Relative safety compared with other NSAIDs: Overall GI and kidney risks are similar to other traditional oral NSAIDs, but some observational studies suggest diclofenac may be associated with a slightly higher rate of cardiovascular events than naproxen or low‑dose ibuprofen, especially at higher doses or with long‑term use; for patients with significant cardiovascular risk, clinicians may prefer an alternative NSAID or non‑NSAID option.

Reporting side effects and staying updated: Patients in the U.S. can report suspected side effects to the FDA MedWatch program (by phone or online) and should review the Medication Guide provided with each prescription for the latest safety information; prescribers and pharmacists can provide up‑to‑date guidance on new warnings or restrictions.

Major drug and supplement interactions: Diclofenac can increase bleeding risk when combined with other NSAIDs, aspirin (especially higher doses), anticoagulants (such as warfarin or direct oral anticoagulants), antiplatelet drugs (such as clopidogrel), and many antidepressants that affect platelets (SSRIs and SNRIs). It can raise levels or toxicity of drugs like lithium, methotrexate, and some immunosuppressants (such as cyclosporine or tacrolimus), and may reduce the blood‑pressure‑lowering or kidney‑protective effects of ACE inhibitors, ARBs, and certain diuretics. Long‑term corticosteroid use, heavy alcohol intake, and supplements with antiplatelet effects (for example, high‑dose omega‑3 fish oil, ginkgo, garlic, or vitamin E) may further increase GI or bleeding risk when combined with diclofenac.

Food, alcohol, and procedures: Diclofenac sodium tablets can usually be taken with or without food, but taking with food may lessen stomach upset (though it may slightly delay absorption). Regular alcohol use—especially heavy drinking—increases the chance of stomach bleeding and liver injury and is best minimized or avoided. Because NSAIDs can stress the kidneys, clinicians may advise caution or temporary discontinuation around major surgery or imaging procedures using iodinated contrast dye in people with kidney disease or other risk factors.

Conditions requiring caution or avoidance: Use is generally avoided in patients with prior serious NSAID or aspirin reactions (including aspirin‑sensitive asthma), active or recent GI bleeding or perforation, severe heart failure, recent or planned CABG surgery, advanced kidney disease, or significant uncontrolled liver disease. Extra caution and risk–benefit assessment are needed in patients with cardiovascular disease or risk factors (such as prior heart attack or stroke, diabetes, smoking, or high blood pressure), in those with a history of ulcers or GI bleeding, and in older adults.

Monitoring needs: For patients using diclofenac regularly, clinicians often monitor blood pressure, kidney function (serum creatinine), and liver enzymes, and may periodically check blood counts for signs of anemia from occult bleeding. Patients and caregivers should be alert for symptoms of heart or stroke events, GI bleeding, allergic reactions, or fluid retention and promptly report them to a healthcare professional.

Q: How long can I safely take diclofenac sodium tablets?
A: For short‑term pain, they are usually used for the briefest period needed, while for chronic arthritis they may be used long‑term under close medical supervision at the lowest effective dose, with periodic checks of blood pressure, kidney function, liver tests, and stomach or heart symptoms.

Q: Is diclofenac stronger or better than ibuprofen or naproxen?
A: Diclofenac often provides similar pain relief to other NSAIDs, but some studies suggest it may carry a somewhat higher risk of cardiovascular problems than naproxen or low‑dose ibuprofen, so the “best” choice depends on your individual heart, stomach, and kidney risk factors.

Q: Can I take diclofenac with my daily low‑dose aspirin?
A: Many people do use both under medical guidance, but the combination can increase bleeding and stomach risk, so your clinician will weigh the benefits, may add stomach protection (such as a proton‑pump inhibitor), and will advise you exactly how and when to take each medicine.

Q: What can I do to reduce stomach problems while taking diclofenac?
A: Using the lowest effective dose for the shortest time, taking tablets with food if allowed, avoiding alcohol and smoking, and, for high‑risk patients, adding a stomach‑protective medication can all help lower the chance of ulcers or bleeding.

Q: When should I stop diclofenac and call my doctor or seek emergency care?
A: Stop the drug and get immediate medical help if you notice chest pain, sudden shortness of breath, weakness or trouble speaking, black or bloody stools, vomiting blood, severe stomach pain, sudden swelling or weight gain, yellowing of the skin or eyes, or a severe rash or breathing difficulty.

Storage: Store diclofenac sodium tablets at room temperature, away from heat, moisture, and direct light, and keep the bottle tightly closed and out of reach of children and pets.

Disposal: Do not keep unused or expired tablets; use a community drug take‑back program if available, or follow pharmacist or local waste guidelines (do not flush unless specifically instructed), and keep tablets in their container until disposal to avoid accidental ingestion.